Clearbridge Investments, LLC Bio Rad Laboratories, Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$576.64 - $649.04 $60.4 Million - $67.9 Million	-104,668 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$547.01 - $662.35 $4.17 Million - $5.05 Million	-7,631 Reduced 6.8%	104,668 $59.8 Million
Q4 2020 Feb 10, 2021	SELL	$510.68 - $643.45 $8.73 Million - $11 Million	-17,096 Reduced 13.21%	112,299 $65.5 Million
Q3 2020 Nov 12, 2020	SELL	$454.43 - $535.6 $5.09 Million - $6 Million	-11,203 Reduced 7.97%	129,395 $66.7 Million
Q2 2020 Aug 14, 2020	SELL	$334.87 - $493.06 $13.1 Million - $19.3 Million	-39,157 Reduced 21.78%	140,598 $63.5 Million
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $959,709 - $1.23 Million	2,999 Added 1.7%	179,755 $63 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $435,152 - $509,286	-1,361 Reduced 0.76%	176,756 $65.8 Million
Q3 2019 Nov 14, 2019	SELL	$304.55 - $345.24 $251,558 - $285,168	-826 Reduced 0.46%	178,117 $59.3 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $1.29 Million - $1.41 Million	4,499 Added 2.58%	178,943 $0
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $3.08 Million - $4.36 Million	13,735 Added 8.55%	174,444 $53.3 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $769,469 - $1.08 Million	3,496 Added 2.22%	160,709 $37.3 Million
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $789,155 - $889,737	-2,728 Reduced 1.71%	157,213 $49.2 Million
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $8.31 Million - $10.3 Million	34,054 Added 27.05%	159,941 $46.1 Million
Q1 2018 May 15, 2018	BUY	$233.97 - $274.11 $29.5 Million - $34.5 Million	125,887 New	125,887 $31.5 Million

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.2B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account